Fig. 2: Duration of response. | Nature Communications

Fig. 2: Duration of response.

From: A multicenter phase 2 trial of camrelizumab plus famitinib for women with recurrent or metastatic cervical squamous cell carcinoma

Fig. 2: Duration of response.

a Kaplan–Meier curve of duration of response. Data are for the 13 patients with confirmed objective responses. b Swimming plot demonstrating the treatment exposure and duration of tumor response in the full analysis population. Two patients who did not have tumor evaluation results at post-baseline and did not die during the study treatment were not included in the swimming plot. The length of the bars corresponds with time from treatment initiation to the last tumor assessment or death.

Back to article page